Friday, January 08, 2016 9:13:55 AM
RE Woodford Funds
http://www.whatinvestment.co.uk/financial-news/funds/2501171/now-may-be-a-and39good-time-to-buyand39-the-woodford-patient-capital-trust.thtml
"Towards the end of 2015, one of the holdings in Woodford’s funds suffered a severe share price setback as short sellers criticised the investment. More than one observer commented that such bumps in the road are inevitable because the capital was invested so quickly, and questioned whether Woodford’s firm could have carried out the extensive due diligence required on such nebulous investments. The investment has cost the Woodford funds close to £16 million.
Read more: Neil Woodford breaks silence on US investment that has lost £16 million
Woodford Investment Management replied that they view the level of due diligence as adequate and the investment remains in the portfolio."
http://www.whatinvestment.co.uk/financial-news/funds/2501171/now-may-be-a-and39good-time-to-buyand39-the-woodford-patient-capital-trust.thtml
"Towards the end of 2015, one of the holdings in Woodford’s funds suffered a severe share price setback as short sellers criticised the investment. More than one observer commented that such bumps in the road are inevitable because the capital was invested so quickly, and questioned whether Woodford’s firm could have carried out the extensive due diligence required on such nebulous investments. The investment has cost the Woodford funds close to £16 million.
Read more: Neil Woodford breaks silence on US investment that has lost £16 million
Woodford Investment Management replied that they view the level of due diligence as adequate and the investment remains in the portfolio."
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
